Sterling Accuris Diagnostics

Sterling Accuris Diagnostics operates a large network of NABL-accredited pathology laboratories across India, offering over 2,000 diagnostic tests and profiles using advanced technology and automation. The company serves hospitals, corporates, B2B/B2C clients, and individuals with a focus on accuracy and reliability. It recently expanded its footprint through the acquisition of Gujarat & Maha Gujarat Pathology Laboratories. No clinical trial results as it does not develop drugs or therapies. The company’s core strengths are in comprehensive diagnostics including molecular diagnostics, histopathology, cytogenetics/genetic testing, immunoassays, microbiology (routine & specialized), protein chemistry/clinical chemistry/hematology/coagulation/infectious disease testing. It maintains high quality standards with ISO/NABL accreditations. As of early 2025 it operates more than 250 labs/collection centers in over four Indian states and serves millions of patients annually.